ABSTRACT: The skeletal phenotype of the cav-1 −/− mouse, which lacks caveolae, was examined. µCT and histology showed increased trabecular and cortical bone caused by the gene deletion. Structural changes were accompanied by increased mechanical properties. Cell studies showed that cav-1 deficiency leads to increased osteoblast differentiation. These results suggest that cav-1 helps to maintain osteoblast progenitors in a less differentiated state.
INTRODUCTION
A MULTITUDE OF GENES influence skeletal size and morphology. Obvious candidates include growth hormone or PTH-related peptide, which directly control skeletal morphogenesis, whereas other genes affect skeletal development through less obvious mechanisms, such as LRP5. (1) Because the hard tissue of the skeleton can be readily evaluated both during embryogenesis and postnatally by size, X-ray, and newer techniques, such as CT, genes that have not previously been considered as regulators of skeletal homeostasis have been serendipitously uncovered. Examples of these are src kinase, which was found to be important for osteoclast function, (2) and less well-understood gene relationships such as GATA-1, which is critical for megakaryocyte development and found to concurrently affect bone formation. (3) Many of the intracellular signals involved in controlling skeletal homeostasis emanate from signaling centers located in plasma membrane lipid rafts. The incoming signal may often be adjusted-amplified, muted, or compartmentalized-as it is transmitted through molecules collected in the raft microdomain. (4) Lipid rafts are cholesterol-and sphingolipid-rich membrane microdomains of varied composition and size. Caveolae are lipid rafts that, by virtue of the caveolin-1 protein scaffold, consist of a 50-to 100-nm vesicular invagination of the plasma membrane. (5) Caveolin-1 contains a 33 amino acid hydrophobic domain that anchors the protein to the membrane, leaving both the amino and carboxyl termini to remain in the cytoplasm and interact with proteins that kind around the central hydrophobic domain. Multiple proteins are recruited to these caveolae through their interaction with caveolin-1. (6, 7) Alterations in caveolin-1 abundance modify signal penetrance, as evidenced by the enhanced mitogen-activated protein kinase (MAPK) signaling when caveolin-1 is silenced (8) or the inhibition of signal generation when caveolin-1 is overexpressed. (9) Recently, cav-1 was shown to co-localize with the membrane associated vitamin D receptor ERp60 in rat and mouse growth plate chondrocytes, (10) and others have reported the presence of VDR in lipid rafts isolated from rat osteoblasts. (11) In summary, caveolae are thought to hold signaling components in check until they are appropriately activated. (12) The cav-1 −/− mouse confirms a central role for the caveolar lipid raft in signal generation. Disruption of the caveolin-1 gene produces mice that are viable and fertile despite having no characteristic caveolae in the plasmalemmal membrane. (13, 14) The mice have multiple phenotypic sequelae of caveolar loss, including vascular dysfunction, and uncontrolled endothelial and fibroblast proliferation, (13, 14) as well as metabolic abnormalities. (15, 16) Endothelial NO synthase is upregulated in the vessels of cav-1 −/− animals, because of lack of sequestration of the enzyme. (14) Alterations in NO physiology may contribute to the hemodynamic abnormalities of the cav-1-deficient animal, (17) but caveolae themselves have been implicated in the ability to sense hemodynamic changes. (18) (19) (20) Caveolae and caveolin-1 have been found in murine and human osteoblasts (21, 22) and chondrocytes. (23) (24) (25) (26) As expected, cav-1-enriched membrane signaling complexes are found in bone cell caveolae, (27) including the Wnt signaling molecule ␤-catenin, (9) which has been shown to be involved in bone development. (1, 28) Interestingly, 8-wk-old cav-1 −/− mice have altered growth plate morphology characterized by hypercellularity and increased numbers of trabeculae. (10) To better understand the role of the caveolar microdomain in bone homeostasis and response to environmental signals, we examined the skeletal phenotype of the cav-1 −/− mouse at 5 and 8 wk. Here we show that the absence of caveolin-1 results in bigger cortical bones and increases the total amount of bone in both the trabecular and cortical compartments. These increases are accompanied by greater mechanical strength. Cellular studies suggest that the etiology of the increased bone size and amount is at least partly caused by direct effects on osteoblast function, because in the absence of caveolin-1, osteoprogenitor cells favor the osteoblast phenotype.
MATERIALS AND METHODS

Mice
Mice with knockout of caveolin-1 were originally generated in a C57BL/6 background described previously. (13) The mice used here were littermates genotyped as wildtype ). Male mice were used for studies. All animal studies were performed with the approval of the Emory University IACUC.
µCT imaging
High-resolution CT images of the right femur of cav-1 −/− and cav-1 +/+ mice (n ‫ס‬ 4 each at 5 wk and n ‫ס‬ 8 each at 8 wk) were obtained using a Scanco VivaCT 40 (10.5 m voxel resolution; Scanco Medical, Bassersdorf, Switzerland). Specific regions of analysis included a 0.44-mm-thick section spanning the distal femoral epiphysis, a 1.52-mmthick region spanning the distal femoral metaphysis, and a 0.23-mm-thick section spanning the femur midshaft diaphysis. (29) The epiphyseal and metaphyseal regions were defined by the onset and completion of the growth plate, respectively, through assessment of serial slices. Image noise was reduced with a low pass filter, and bone was identified using a fixed threshold. User-guided contour subroutines were used to isolate trabecular bone from the cortical shell at the trabecular sites, whereas automated contour subroutines were used to define bone at the cortical sites. Standard Scanco software using direct distance transformation methods was implemented to determine microarchitecture morphology at the trabecular sites. (30, 31) Parameters derived at the femur epiphysis and metaphysis included tissue volume (mm ) were determined through the scanned volume of bone. Cortical thickness defined by the ratio of bone volume to bone surface (mm) was assessed. Finally, mean maximum (I max ) and minimum (I min ) moments of inertia were determined through the scanned volume (mm 4 ). The specimens were blinded before imaging and analyses. Independent t-tests were performed to assess between group differences because none of the data violated assumptions regarding homogeneity of variance.
A single 5-wk-old cav-1 −/− mouse was excluded from the cortical CT assessment because of fracture of the femur diaphysis during dissection. Because the trabecular data from this sample were within the range of the other 5-wkold cav-1 −/− mice, the trabecular data from this sample were included in the analyses.
Histomorphometry
Five cav-1 +/+ and four cav-1 −/− mice at 8 wk of age and three each at 5 wk were used for histology and morphometric study. Calcein (25 mg/kg body weight; Sigma Chemical, St Louis, MO, USA) was injected intraperitoneally at 6 and 2 days before harvest. After death, the right leg was dissected, and the femur was separated from skin and muscle. Femora were fixed in 70% ethanol and stored in the dark at 4°C.
After dehydration in a graded series of ethanol (70%, 95%, and 100%), the femurs were infiltrated and embedded without decalcification in methylmethacrylate. A longitudinal midsagittal section of each femur was cut at a . Using these measurements, MAR and BFR were calculated. All nomenclature and calculations of the histomorphometric indices were according to Parfitt et al. (32) As well, some slides were stained with oil red-O to assess the number of adipose cells in the bone marrow.
Mechanical testing
To determine if any change in size of the cortical bones was correlated with altered mechanical properties, eight each of cav-1 +/+ and cav-1 −/− mice at 8 wk of age were used for mechanical testing. The diaphysis of the right femurs were mechanically tested in four-point bending (Fig. 1A ) on an electroforce system (ELF3200; EnduraTec) at a constant displacement rate of 0.05 mm/s. From the load displacement data, the following parameters were directly determined: yield deflection, force, maximum load, postyield deflection, and linear stiffness (Fig. 1B) . Using these data and areal data from the mid-diaphysis, the elastic modulus, yield stress, and ultimate stress were determined.
Osteoblast and osteoclast progenitor cells
Osteoprogenitor cells were harvested from the marrow stromal compartment and plated with the same numbers from each genotype. For assessment of osteoprogenitor cells, whole bone marrow was aspirated from femora and tibias of 4 wk-old mice as described. (33, 34) Two million cells were plated in each well of a 6-well plate and cultured in ␣-MEM containing 10% FBS. Nonadherent cells were removed the next day, and 10 mM ␤-glycerophosphate and 50 g/ml ascorbate were added. The media were changed every 3-4 days. To quantify the number and area of von Kossa-positive nodules after 21 days, cultures were fixed in 70% ethanol and stained with von Kossa silver stain. A semiautomated computerized video image analysis system (Optomax 5; Optomax, Hollis, NH, USA) was used to quantitate nodules/surface events in each well. (35) To determine whether the cells exhibited an osteoblastic phenotype characterized by high alkaline phosphatase (ALP), we examined this protein after 14 days of culture with mineralizing media. (35, 36) The osteoclast-generating capacity of the cav-1 −/− marrow cells was probed by culturing whole marrow in the presence of 1␣,25(OH) 2 D 3 sufficient to stimulate RANKL expression from marrow stromal cells causing entry of monocytic precursors into the osteoclast lineage. (37) To measure the ability of the marrow to form osteoclasts, we used an osteoclast-generating system as previously described. (34) Bone marrow cells (4 million/ml) were plated in 24-well plates, and 10 nM 1␣,25(OH) 2 D 3 was added. After 7 days in culture, osteoclasts were identified by staining for TRACP using a kit (Sigma).
CIMC-4 osteoblast cells (36) were used to assess the effect of caveolin knockdown on ALP expression. Cells were treated with siCav or scrambled siRNA in media with the addition of 50 mg/ml ascorbate to promote osteoblastic differentiation. ALP was assayed by standard techniques. 
Requirement for cav-1
siRNA targeting murine caveolin-1 (siCav1) was purchased from Ambion (Austin, TX, USA) and used in culture at the dose indicated. For studies, siCav1 or a control siRNA (siSCR) was added to culture for 2 days before analysis of phenotypic characteristics. Total RNA was isolated by using RNAeasy mini kit (Qiagen, Valencia, CA, USA) and treated with DNase I to remove contaminating genomic DNA. Reverse transcription was performed with 1 g of RNA in a total volume of 20 l per reaction. Realtime PCR was performed using the iCycler instrument (Bio-Rad, Hercules, CA, USA). Amplification reactions were performed in 25 l containing primers at 0.5 M and dNTPs (0.2 mM each) in PCR buffer and 0.03 U Taq polymerase along with SYBR-green at 1:150,000 (Molecular Probes, Eugene, OR, USA). Aliquots of cDNA were diluted 10-to 10,000-fold to generate relative standard curves to which sample cDNA was compared. For RANKL, 18S, (38) osterix (Osx), and Runx2, (36) PCR primers were as in the cited publications. Dilution curves showed that PCR efficiency was >95% for all species studied. PCR products from all species were normalized for amount of 18S in the same RT sample, which was also standardized on a dilution curve from RT sample.
RESULTS
Skeletal structure in the absence of caveolin-1
Weight and crown-rump lengths were measured weekly (3-7 wk) in cav-1 −/− and cav-1 +/+ animals; there were no significant differences either in the rate of growth or the final size between genotypes. Weight plateaued by 6 wk. At 3 wk, the crown-rump length of cav-1 −/− mice (52.86 ± 5 mm) was not different from that of the cav-1 +/+ group (54.6 ± 4.4 mm). The weights of cav-1 −/− and cav-1 +/+ groups were 9.4 ± 2.1 and 9.7 ± 2.38 g, respectively. At 7 wk, the crown-rump length in the cav-1 −/− group was 75.3 ± 2.7 and 74.4 ± 1.4 mm in cav-1 +/+ ; weights of cav-1 −/− and cav-1 +/+ were 23.6 ± 2.5 and 22.6 ± 0.8 g, respectively.
The effect of deletion of caveolin-1 on trabecular bone was region specific, as shown by CT analysis. At 5 wk, within the distal femoral epiphysis, cav-1 −/− mice showed a significant increase in BV/TV (+58.4%, p ‫ס‬ 0.05), arising 
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largely out of increased bone volume (Table 1 ; Fig. 2A) , with increases in both trabecular number and thickness compared with cav-1 +/+ mice. By 8 wk, the bone phenotype at this site converged such that cav-1 −/− mice showed nonsignificant decreases in both tissue volume and bone volume compared with cav-1 +/+ mice, resulting in unchanged BV/TV (−1.8%, p ‫ס‬ 0.27). In contrast, at the distal femoral metaphysis, the timing was reversed: a morphological change was not observed at 5 wk but was profound at 8 wk. At this time, tissue volume was increased 25.3% in cav-1 −/− mice (p ‫ס‬ 0.005). Bone volume at this time was increased to an even greater extent, an increase of 77.4% (p ‫ס‬ 0.008), resulting in a 48.8% increase in metaphyseal BV/TV for the cav-1 −/− mice compared with cav-1 +/+ mice (p ‫ס‬ 0.02; Fig. 3A) . When the metaphyseal region was subdivided into two equal length regions, the region closest to the epiphysis showed a 37.1% increase in BV/TV in cav-1 −/− mice, whereas the region farthest from the epiphysis (i.e., closer to the mid-diaphysis) showed an 82.8% increase in BV/TV. Compared with cav-1 +/+ mice, the metaphyseal trabeculae of cav-1 −/− mice were significantly greater in number (+22.0%, p ‫ס‬ 0.02) and showed reduced spacing (−17.8%, p ‫ס‬ 0.03). Trabecular thickness did not differ significantly between cav-1 −/− and cav-1 +/+ mice (5.6%). At the femoral mid-diaphysis of cav-1 −/− mice, the total cortical area was increased at both 5 and 8 wk (+19.7 and +13.8%, respectively), with significantly expanded periosteal and endocortical surfaces at 8 wk (Fig. 2B ). In the 8-wk-old mice, the periosteal area of cav-1 −/− mice exceeded that of cav-1 +/+ mice by 16.3% (p ‫ס‬ 0.004). The endocortical area of cav-1 −/− mice was similarly larger than cav-1 +/+ mice (18.6%, p ‫ס‬ 0.01). The cortical thickness between cav-1 −/− and cav-1 +/+ mice was equivalent (−1.2%). As a result of endocortical and periosteal expansion, I max (38.2%, p ‫ס‬ 0.003) and I min (23.7%, p ‫ס‬ 0.03) were both significantly larger in cav-1 −/− mice at 8 wk. These data are shown in Table 1 .
Histology and histomorphometry confirm µCT data
Static and dynamic histomorphometry of a separate cohort of animals injected with calcein at 6 and 2 days before death at 5 ( Table 2 ) and 8 wk (Table 3 ) was performed. The data indicated that the increased metaphyseal and cortical bone at 8 wk arose from earlier increased bone formation rate. As shown in Table 2 , the BFR in the cav-1 −/− mice is nearly twice that of its wildtype littermate. Histomorphometry from 5-wk-old mice showed a trend toward increased BV/TV%, consistent with the CT data. A similar increase in bone formation rate was measured at the cortical site, where there was already a trend toward an increase in cortical bone by CT and histomorphometry (Tables 1 and 2) .
At 8 wk, shown in Table 3 (Table 3) showed a significant increase in total cortical bone accompanying deletion of caveolin-1 of +73.5%. As in the trabecular assessment, there was a decreased MAR (−67.8%) and BFR (−64.7), suggesting that the increase in bone occurred before the 8-wk study. Decreased osteoblast surface in the 8-wk-old cav-1 −/− animals was congruent with the decreased MAR.
Mechanical testing of skeletal strength in the absence of caveolin-1
Mechanical testing of the femoral diaphysis, performed from the 8-wk-old samples, showed that the increases in bone tissue were correlated with increased material properties. The I max and I min calculated from the CT analysis of cortical bone, which showed significant increases of 38% and 23%, respectively (Table 1) , are reflected in the significant 33% increase in stiffness and 33% decrease in postyield deflection seen in the cav-1 −/− animals (Table 4 ), indicating that these bones were both stiffer and less bendable. These material properties contributed to a significant 25% increase in maximum force. 
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cav-1 −/− marrow cells produce more von Kossa-positive nodules
To gain insight into the etiology of the changes in bone size and mechanical properties in the cav-1 −/− mouse, we asked whether any of the effects of caveolin-1 in the skeleton could be ascribed directly to those cells responsible for bone formation and resorption. As shown in Fig. 4A , the cav-1 −/− stromal cultures grown for 21 days in media containing ascorbate and ␤-glycerophosphate had significantly more von Kossa-positive area compared with stromal cultures harvested from cav-1 +/+ littermates, although the amount of ALP was not significantly different (Fig. 4B) . The greater levels of von Kossa-positive precipitate in the matrix produced by cav-1 −/− cells suggested an increased tendency of osteoprogenitors to respond to signals that induce differentiation.
Changes in bone quantity may also be caused by altered resorption, but the osteoclast-forming potential of the marrow was not decreased by caveolin-1 deletion. After 7 days in the presence of 1␣,25(OH) 2 D 3 , there was no appreciable difference in TRACP + multinuclear cell numbers (representing osteoclasts) between cav-1 −/− and cav-1 +/+ cultures as can be appreciated from macroimages of culture plates (Fig. 5) . We also counted osteoclasts in two experiments. In 
FIG. 4.
Effect of caveolin-1 status on response to mineralization media. Bone marrow cells from 4-wk-old cav-1 −/− or cav-1 +/+ mice were cultured in mineralizing media for 14 days and stained for ALP to detect osteoblast colony formation or after 21 days for von Kossa stain to detect mineralization. Cultures in cav-1 −/− showed increased von Kossa-positive area. *Significant increase in mineralization area of cav-1 −/− cultures (p < 0.004). ALP staining area was not significantly changed between caveolin-1 phenotypes.
the first experiment, cav-1 +/+ versus cav-1 −/− marrow cultures generated 230 ± 10 compared with 265 ± 12 TRACP + , multinuclear osteoclasts, (39) and in the second, 106 ± 10 compared with 131 ± 12, respectively (n ‫ס‬ 6 for each). Data combined from these two experiments show that osteoclast generation in marrow cultures made from cav-1 −/− mice had 20 ± 7% more osteoclasts than cav-1 +/+ cultures, an increase that was significant (p < 0.05).
Silencing caveolin-1 enhances expression of osteoblast phenotypic characteristics
To determine whether changes in the osteoblastic potential of the cav-1 −/− marrow cells could be ascribed to a direct effect, we examined if silencing caveolin-1 in wildtype primary stromal cell cultures would alter the expression of osteoblast markers. We used a single siRNA targeted against caveolin-1 (siCav-1) that dose-dependently inhibited expression of caveolin-1 mRNA when added to stromal cell cultures at day 5 (Fig. 6, inset) . Partial caveolin-1 silencing resulted in increased levels of mRNA for osterix and Runx2, transcription factors essential for osteoblast differentiation. (40, 41) This effect became significant at the 40 nM dose of siCav-1 (Fig. 6A) . siCav-1 also caused a significant and dose-dependent decrease in RANKL mRNA expression, which can be attributed to a more mature phenotype. (42) The effect of caveolin-1 silencing on ALP was studied in an osteoblast cell line, CIMC-4. (36) In these experiments, caveolin-1 siRNA at 50 nM caused a reduction in cav-1 mRNA of at least 80%, with a 75% decrease in cav-1 protein (data not shown). As shown in Fig. 6B , in cells treated with siCav-1, ALP rose significantly at 72 h compared with those treated with a scrambled siRNA.
DISCUSSION
Mice lacking caveolin-1 have system-wide changes that result from the inability of cells to respond to regulatory factors through a caveolae-dependent mechanism. We previously showed that growth plates are altered in these mice, (10) suggesting that there are effects on skeletal development and homeostasis as well. The results presented here show that cav-1 deficiency precipitates a significant skeletal phenotype and suggest that this phenotype is caused, in part, by altered osteogenic potential of bone marrow. The skeletal changes represented significant increases in both trabecular and cortical bone area. At the whole bone level, cav-1 deletion resulted in stiffer bones capable of bearing greater load before failure. As such, the role of caveolin-1 as a sorting station for cellular reception of growth and differentiation signals (43, 44) is now extended to effects on bone cells.
Interestingly, we found a pronounced cav-1 −/− trabecular phenotype that first appeared as increased bone volume in 
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the epiphysis at 5 wk, and by 8 wk, in the metaphysis. This could be directly attributed to the absence of caveolin-1, because the littermate cav-1 +/+ mice exhibited normal trabecular histology. The differential influence of cav-1 −/− on the epiphysis earlier and metaphysis later may reflect differences in the development of these two skeletal regions. The epiphysis is established during embryonic bone formation, whereas the metaphysis of the postfetal mouse is still undergoing dynamic remodeling through endochondral ossification and has much greater bone surface area in contact with marrow. The progressive phenotype in the cav-1 −/− mouse, first observed in the epiphysis and then the metaphysis, suggests that the influence of caveolin-1 deficiency is most pronounced during maximal developmentally driven bone formation.
The histomorphometry data provide cellular substantiation of the CT data and indicate that the effect of caveolin-1 knockout on bone formation predominates during the early postnatal stages of skeletal development. MAR and BFR are increased at both metaphyseal and cortical sites in the 5-wk-old caveolin-1 knockout skeleton (Table 2) , regressing by 8 wk. These data indicate that the trabecular and cortical bone phenotypes seen in the cav-1 −/− mouse were established earlier in development, with the normal balance between osteoblast and osteoclasts tilted toward osteoblast activity resulting in increased morphology, accelerated mineralization, and increased bone strength.
Notably, the caveolin-1-deficient mouse has a normal skeletal shape, suggesting that homeobox genes controlling the skeleton do not interact with caveolin-1 signal modulation. However, the growth of bone within the skeleton leads to increased size of the cortical compartment and increased hard tissue within the trabecular compartment, indicating that the parameters defining bone morphology during postfetal skeletal maturation are filtered through a caveolar lens. Because the caveolin-1-deficient state in this transgenic is not limited to bone cells, and there are myriad levels at which bone structure and morphology are controlled, it is not possible to define the exact mechanism by which caveolin-1 exerts control on the skeleton. The combination of data developed at different levels may allow initial insights into how the bone phenotype was achieved.
Our cellular studies suggest that the osteoclast potential in the marrow of the cav-1 −/− mice was increased. However, whereas there are many complex issues that we have not undertaken here with regard to hormone responsiveness of the cells involved in osteoclastogenesis, it is most likely that the modestly increased osteoclastogenic potential represents a more active remodeling process in cav-1 −/− mice during a time when bone formation is accelerated. Indeed, osteoblast potential was distinctly enhanced by caveolin-1 deletion. The von Kossa assay reflects mineralization capacity as an indicator of osteoblast function of marrow cells. These results indicate that osteoprogenitor cells deficient in caveolin-1 will generate more mineral deposition. The relationship of the mineral deposited by the stromal cells to their extracellular matrix was not examined, so it is not known if the increases in von Kossa-positive deposits reflect normal mineralization or if they resulted from dystrophic calcification. (45, 46) Moreover, osteoblast cells treated with siRNA targeting caveolin-1 showed greater ALP elaboration. Finally, stromal cells where caveolin-1 was targeted by siRNA knockdown expressed higher levels of two factors associated with osteoblastic differentiation, Runx2 and osterix, (40) as well as a lower level of RANKL, which has also been linked to a later differentiation stage, (42) than did stromal cells transfected with nonsense siRNA.
In summary, our results suggest that caveolin-1 serves to restrain osteoblast differentiation. The fact that caveolin-1 is critical for caveolae per se to exist supports the hypothesis that osteoblast differentiation is regulated by signals that are transmitted through these membrane structures. Caveolin-1 may serve to mute the intracellular signals that continuously impact the osteoprogenitor cells by damping those incoming signals that lead to osteoblast differentiation. Although this issue is highly speculative, the literature suggests that in the absence of caveolin-1 some cells proliferate (i.e., alveolar cells), whereas other cells do not. (8, 14, 47) In the case of osteoprogenitor cells, it would seem that caveolin-1 serves to constrain the emergence of the osteoblast phenotype. Very provocatively, Sotgia et al. (48) have shown that caveolin-1-deficient mice have an increased mammary stem cell population that is characterized by hyperactivation of the Wnt/␤-catenin signaling system. This may be caused by an association of ␤-catenin with caveolae, because the recruitment of ␤-catenin by caveolin-1 to caveolar membrane may allow sequestration of this signaling molecule. (9) Translocation of ␤-catenin into the nucleus through the canonical Wnt pathway activates genes that induce osteoblast differentiation and renewal of the stem cell population, (49) a process that could be inhibited by caveolae. Another possibility is that the effects of bone morphogenetic proteins (BMP) are enhanced in the absence of caveolae; BMP receptors can be found within caveolae, and caveolin-1 can inhibit BMP signaling. (50) Exploration of these findings will be important for future work.
